Product Highlight - DAYVIGO

• For the treatment of insomnia¹.

• Lemborexant, like other sleep-promoting drugs, may impair daytime wakefulness even when used as prescribed.
Prescribers should advise patients about the potential for next day somnolence. The risk of daytime impairment is increased if lemborexant is taken with less than a full night of sleep remaining, or if a higher than the recommended dose is taken¹.

Reference:
1. Full product information of Lemborexant (Dayvigo).